The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| MELI KASZEK PIONEER CORP | CLASS A ORD | G5S74L106 | 6,930 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| GUIDEWIRE SOFTWARE INC | COM | 40171V100 | 19,997 | 281,689 | SH | SOLE | 281,689 | 0 | 0 | ||
| COUPANG INC | CL A | 22266T109 | 78,115 | 6,126,664 | SH | SOLE | 6,126,664 | 0 | 0 | ||
| MODERNA INC | COM | 60770K107 | 21,428 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| NU HLDGS LTD | ORD SHS CL A | G6683N103 | 52,129 | 13,938,154 | SH | SOLE | 13,938,154 | 0 | 0 | ||
| LIGHT AND WONDER | COM | 80874P109 | 83,911 | 1,785,714 | SH | SOLE | 1,785,714 | 0 | 0 | ||
| CNFINANCE HOLDINGS LTD ADR | SPON ADS | 18979T105 | 68 | 26,509 | SH | SOLE | 26,509 | 0 | 0 | ||
| GINKGO BIOWORKS HOLDINGS INC | CL A SHS | 37611X100 | 2,623 | 1,102,044 | SH | SOLE | 1,102,044 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 43 | 9,367 | SH | SOLE | 9,367 | 0 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 568 | 44,314 | SH | SOLE | 44,314 | 0 | 0 | ||
| VACASA INC | CLASS A COM | 91854V107 | 3,921 | 1,361,470 | SH | SOLE | 1,361,470 | 0 | 0 | ||